Connect your AI

Exagen Inc. XGN Increase (decrease) in contract liabilities and current deferred income

Increase (decrease) in contract liabilities and current deferred income at other companies

SPS CommerceSPSC

$4.87M+54.2%

AvePoint, Inc.AVPT

$4.39M+4.3%

Q2 HoldingsQTWO

$45.49M+26.0%

Franklin CoveyFC

-$2.73M+61.5%

AMN HealthcareAMN

-$4.41M-312%

Silvaco Group, Inc.SVCO

-$2.14M-668%

Other financials

Income statement

Revenue$17.3M+11.7%

Gross profit$10.2M+11.9%

Operating income-$3.4M-1.5%

Net income-$4.0M-5.7%

EPS (diluted)-$0.17+15.0%

Balance sheet

Cash & equivalents$21.7M+90.6%

Total debt$27.1M+15.8%

Total equity$14.4M+125%

Total assets$52.0M+28.9%

Cash flow

Operating cash flow-$10.4M+2.4%

CapEx$228.0K+102%

Free cash flow-$10.6M+1.3%

Valuation

Market cap$112.34M-28.2%

Enterprise value$117.78M-22.1%

P/S1.6×-1.0×

Profitability

Gross margin58.3%-1.0pp

Operating margin-20.6%-2.9pp

Net margin-29.5%+2.5pp

FCF margin-27.5%—

Returns & leverage

Return on equity-193.6%+355pp

Debt / equity1.9×-1.8×

Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s increase (decrease) in contract liabilities and current deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Exagen Inc.'s increase (decrease) in contract liabilities and current deferred income?: Exagen Inc. (XGN) reported increase (decrease) in contract liabilities and current deferred income of $6K in Q1 2026.
How has Exagen Inc.'s increase (decrease) in contract liabilities and current deferred income changed year-over-year?: Exagen Inc.'s increase (decrease) in contract liabilities and current deferred income decreased by 95.8% year-over-year, from $143K to $6K.